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Abstract
Background: The aims of this field trial were to describe the clinical-pathologic findings in calves with otitis media
(OM) and media-interna (OMI), to evaluate, through the development of a scoring system, the effectiveness of a
standardized therapeutic protocol, and to identify the causative pathogens and their possible correlation with
concurrent respiratory disease. All animals underwent physical and neurological examinations at three experimental
time points: at diagnosis/beginning of treatment (T0), 1 week (T1) and 2 weeks (T2) after therapy was started,
respectively. Follow-up telephone interviews with animal owners were conducted 1 month later. The therapeutic
protocol consisted of tulathromycin (Draxxin®; Zoetis), oxytetracycline hydrochloride (Terramicina 100®; Zoetis), and
carprofen (Rimadyl®; Zoetis).
Results: Twenty-two calves were enrolled. Physical and otoscopic examination at T0 revealed monolateral and
bilateral otorrhea in 16 and 6 calves, respectively, with peripheral vestibular system involvement in calves
presenting with neurological signs (n = 17; 77 %). A significant improvement of clinical and neurological scores was
observed in 20 (90 %) calves, a full recovery in only 1 (5 %). One calf worsened between T0 and T1 and it was
removed from the study. None of the other animals showed a worsening of clinical conditions and/or required
further treatments at one month follow up. Mycoplasma bovis was isolated in 89 % of the affected ears either alone
or together with P. multocida (n = 5), Streptococcus spp. (n = 1), Staphylococcus spp. (n = 1), and Pseudomonas spp.
(n = 1). M. bovis either alone or together with these bacteria was also isolated from the upper and/or lower
respiratory tract in 19 (86 %) calves.
Conclusions: This is the first prospective study to evaluate the effectiveness of a standardized therapeutic protocol
for the treatment of OM/OMI in calves. The therapy led to clinical improvement in the majority of the calves.
Persistence of mild clinical-neurological signs did not compromise productive performance. The numerical scoring
system for clinical and neurological signs permitted objective evaluation of response to therapy. M. bovis was the
pathogen most often isolated. This finding should be considered in the treatment of OM/OMI in calves. Moreover,
respiratory tract infection should not be underrated, since it is one of the major risk factors for the development of
OM/OMI.
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Background
Otitis media (OM) and media-interna (OMI) are common
diseases in cattle. They can occur either sporadically or as
an outbreak [1], causing economic losses [2]. Young ani-
mals, from 1 week to 18 months of age, are usually af-
fected [2, 3], although OM has also been reported in
an adult cow [4]. No gender predisposition has been dem-
onstrated but inclement weather has been associated with
increased incidence [5–9]. Reportedly, beef calves are
more often affected, though the incidence of OMI seems
to be rising among dairy calves, as well [6–8, 10, 11]. OMI
occurs frequently in association with respiratory infec-
tions, and the same causative pathogens have been iso-
lated [1, 8]. The most common route of infection is
through the Eustachian (auditory) tube. The pathogens
can also reach the middle ear by hematogenous spread or
by migration from the external ear, which occurs primarily
in cases of parasitic otitis [1, 6, 8, 12, 13]. Mycoplasma
bovis, either alone or in association with other bacteria, is
considered one of the main etiological agents of OMI in
calves [1, 8, 10, 13]. Clinical signs of OM and OMI vary
from conjunctival discharge, pain, obtundation, poor ap-
petite and pyrexia [5, 7, 8, 14, 15] to neurologic manifesta-
tions secondary to facial nerve (cranial nerve VII) and
vestibulocochlear nerve (cranial nerve VIII) dysfunctions
[1]. Purulent aural discharge may appear into the external
acoustic meatus in association with rupture of the tym-
panic membrane. Increased pressure into the tympanic
bulla due to the exudate filling the cavity can cause the
membrane to rupture [2, 9]. Complications of OMI are ill
thrift and intracranial extension with worsening of neuro-
logical signs [8, 11]. To prevent economic losses due to
treatment costs and weight faltering, diagnosis should be
made during the early or subclinical stages of the disease
[12, 16]. The presumptive clinical diagnosis is based on
physical and neurological evaluation and can be confirmed
by otoscopic examination and other diagnostic imaging
techniques [8, 11, 16, 17]. A definitive diagnosis of OM
and OMI is reached at necropsy, as well [1]. Treatment in
the acute stages has been effective, while poor response to
therapy has been related to chronicity or development of
complications [1, 2, 8, 12].
Prospective studies on the effectiveness of therapeutic
standardized protocols for OM and OMI in calves are
lacking to date. The hypothesis of this study were to
evaluate if a standardized therapeutic protocol can be
used in the treatment of OM and OMI in veal calves
and if it is possible to assess objectively the response to
therapy. The primary aims of this field trial were (1) to
describe the clinical-pathologic findings in calves with
OM and OMI and (2) to evaluate, through the develop-
ment of a scoring system, the effectiveness of a stan-
dardized therapeutic protocol. A secondary objective
was to identify causative pathogens and their possible
correlation with concurrent bovine respiratory disease
(BRD) in Italy, in the referred population.
Methods
The study was performed according to ethical recom-
mendations, animal welfare considerations and regulations
(Directive 98/58/EC and Italian Decree Law 146/2001).
Moreover, for any patient referred at Teaching Hospital of
the Department of Veterinary Science of Turin (Italy) the
owner or an agent for the owner had to read and sign an
informed owner consent in order to authorize any veterin-
ary assessment and treatment needed for his/her animal.
Calves referred to the Teaching Hospital of the Department
of Veterinary Science of Turin (Italy) between February
2013 and December 2014 for suspicion of acute OM and
OMI were selected for the study. Animals were recruited if
they had not received treatment, had undergone physical
and neurological examination, if OM and/or OMI
were confirmed by aural examination by means of oto-
scopy/endoscopy, and if follow-up records were available.
All animals underwent bilateral otoscopic examination
with a hand-held otoscope (Heine Beta®TR 3.5 V re-
chargeable handle, Heine G-002.21.301 slit illumination
head, 65 mm× 6 mm diameter closed specula, Heine
Optotechnik, Herrsching, Germany); in selected cases,
endoscopic examination was carried out using a laparo-
scope (Karl Storz GmBH, Tuttlingen, Germany, Ottica
Hopkins II, 2.7 mm× 15 cm).
Physical and neurological examination
Physical and neurological examinations were per-
formed at three experimental time points: at diagno-
sis/beginning of treatment (T0), 1 week (T1) and
2 weeks (T2) after therapy was started, respectively.
During follow-up telephone interviews with the
owners 1 month after T2, information was collected
on the animals’ mental status, appetite, weight gain,
possible worsening and further treatments. Physical
examination was based on a protocol tested and opti-
mized in a previous pilot study (data not shown).
Neurological examination was performed by a board-
certified neurologist (ADA). A two-part standardized
data collection form, one for physical and one for
neurological findings, was completed for each animal.
The scoring system for clinical signs was derived
from the Calf Respiratory Scoring Chart, University of
Wisconsin [18]1. The scoring system for neurological
signs was devised on the basis of a previous pilot
study by the authors. Tables 1 and 2 show the nu-
merical scoring systems used to quantify the clinical
and neurological findings, respectively, at each experimen-
tal time point. A final total score (clinical + neurological
scores) was then obtained for each animal at each
time point.
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Sample collection and analysis
All procedures were conducted in sterile conditions to ex-
clude sample contamination. With the exception of blood
samples, all biological specimens were collected with the
animal sedated with xylazine (Rompun®, Bayer Health
Care, Monheim, Germany) (IV 0.05 mg/kg). Two blood
venous samples (5 mL/aliquot) were collected from the
jugular vein of each animal: one aliquot was collected in
an EDTA tube for hemocromocytometric analysis, the
other was collected into a serum vacuum tube for bio-
chemical profile (alanine transaminase [ALT], aspartate
transaminase [AST], alkaline phosphatase [ALP], creatine
phosphokinase [CPK], gamma-glutamyltranferase [GGT],
total bilirubin, blood urea nitrogen [BUN], creatinine, glu-
cose, total serum protein, albumin, total calcium, magne-
sium, sodium, phosphorus, and potassium concentrations).
Cerebrospinal fluid (CSF) was aseptically collected
from the lumbosacral site of each animal, as previously
described [19]. CSF analysis was performed within 1 h of
collection. Total nucleated cell count, differential cell
count and total protein concentration were assessed.
Nasal and aural swabs were collected using sterile swabs
from both nares and ears of each animal. Tracheobron-
chial aspiration (TBA) was performed as previously de-
scribed [20]. Ear exudate was collected by means of a
sterile disposable dog catheter (2.0 × 500 mm. Buster®;
Kruuse, Langeskov, Denmark) gently inserted through a
sterile otoscope speculum into the affected ear canal and
flushed with 2.5 mL of warm sterile saline solution. The
aspirated fluid was then placed in a sterile tube. Aural,
nasal and tracheobronchial samples were stored at 0–4 °C
until processing.
Bacterial cultures and M. bovis identification were car-
ried out at the Istituto Zooprofilattico Sperimentale della
Lombardia e dell’Emilia Romagna (Brescia, Italy). Blood
agar, brain heart infusion agar and MacConkey agar were
used for bacteriological cultures. Cultures were incubated
Table 1 Classification of severity (score) of clinical findings in
calves with otitis
Score Clinical findings
Rectal Temperature
0 ≤ 39.2 °C
1 39.3 °C < T° < 40 °C
2 ≥ 40 °C
Feces
0 Normal feces
1 Feces softer than normal, but no
diarrhea on tail
2 Diarrhea but not profuse, wet tail
3 Profuse watery diarrhea with blood
and fibrin, wet tail
Respiratory System
0 No respiratory signs
1* Induced or spontaneous cough
1* Nasal discharge
1* Eye discharge
*one point for each sign
Otoscopic Examination
0 Absence of purulent material
1* Presence of purulent material
*one point for each side (left/right)
Joints
0 No signs of arthritis
1* Presence of arthritis
*one point for each affected joint
Table 2 Classification of severity (score) of neurological findings
in calves with otitis
Score Neurological findings
Mental Status
0 Normal
1 Depressed
2 Stuporous
Posture
0 Normal
1 Head tilt
2 Recumbent - unable to stand
Gait
0 Normal
1 Vestibular ataxia
2 Hemiparesis/Hemiplegia
3 Tetraparesis/Tetraplegia
Proprioceptive Testing
0 Normal
1 Ipsilateral Decreased proprioceptive positioning reaction
2 Bilateral Decreased proprioceptive positioning reaction
Cranial Nerve Assessment
0 No cranial nerve deficits
1a Anisocoria
1a Positional strabismus (III, IV, VI, VIII)
1a Patological nystagmus (III, IV, VI, VIII)
1a Abnormal facial sensation perception (V)
1a Abnormal chewing and muscle tone (V)
1a Ear droop, eyelid droop, upper lip droop
Absence of palpebral reflex and menace response (VII)
1a Abnormal swallowing (IX, X)
1a Abnormal tongue size and asymmetry (XII)
aone point for each side (right/left)
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with 10 % CO2 at 37 °C for 24/48 h. Mycoplasma cultures
were performed on PPLO (pleuropneumonia-like organ-
isms) bovine agar and broth and incubated for 7 days at
37 °C in microaerophilic condition. M. bovis was identified
by polymerase chain reaction (PCR) assay according to a
validated method [21].
Treatment
All animals underwent a standardized therapeutic protocol
at T0. Each calf received tulathromycin (Draxxin®; Zoetis)
(single subcutaneous injection of 2.5 mg/kg), oxytetracyc-
line hydrochloride (Terramicina 100®; Zoetis) (intramus-
cular injection of 9.27 mg/kg for 5 consecutive days), and
carprofen (Rimadyl®; Zoetis) (subcutaneous injection of
1.4 mg/kg, repeated the fourth day). The referring veterin-
arian was instructed to continue the treatment from day 6
to 14 with an oral formulation containing oxytetracycline
hydrochloride (10 mg/kg twice a day).
Statistical analysis
Statistical analysis was performed using the R2 1.0 free-
ware statistical software package (R Commander 2.0–4).
The Shapiro-Wilk normality test was used to determine
normal data distribution. Numerical data are presented as
mean, frequency and/or percentage. A pairwise Wilcoxon
rank sum test was used to assess the effect of treatment
on clinical and neurological findings in relation to the ex-
perimental time points. Statistical significance was set at
P ≤ 0.05 and Bonferroni correction was applied for mul-
tiple comparisons.
Results
Twenty-two calves were enrolled in the study. The ani-
mals (18 males and 4 females, mean age 77 days, range
20–180) came from eight different herds. The breed types
were Italian-Holstein Friesian (n = 9, 41 %), Piedmontese
(n = 3, 13 %), Limousine (n = 1, 5 %), Belgian Blue (n = 1,
5 %), and cross-breed (n = 8, 36 %); 16 (73 %) were re-
ferred during the autumn and winter and the remaining 6
(27 %) during the spring and summer months.
Physical and neurological examination
Physical and otoscopic examination at T0 revealed mono-
lateral and bilateral otorrhea in 16 and 6 calves, respect-
ively. Endoscopic examination was carried out by a single
endoscopist (PG) at T0 in 11 calves. The tympanic mem-
brane could not be visualized in any of the animals. Seven-
teen (77 %) animals had abnormal neurological findings
and five did not. The peripheral vestibular system was in-
volved in all calves presenting with neurological signs.
None of the animals showed signs of arthritis or a cranial
nerve score >5. Figures 1 and 2 present the clinical and
neurological findings at T0 and T2.
Head tilt and vestibular ataxia were the only posture and
gait abnormalities observed, respectively. Positional strabis-
mus and motor dysfunction of facial nerve (VII), alone or
in combination, were the most common findings on cranial
nerve assessment at each time point. A significant differ-
ence in the clinical (Fig. 3) and neurological (Fig. 4) scores
was found between T0 and T2. A significant difference in
the final total score was found between T0 and T1, and T0
and T2 (Fig. 5). Deterioration of neurological conditions
Fig. 1 Most common clinical findings at diagnosis (T0) and at 2 weeks after therapy (T2)
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with central vestibular system deficits occurred in 1 calf be-
tween T0 and T1. For welfare reasons, the animal was
treated with a different therapeutic protocol and excluded
from assessment at T2.
A significant improvement of clinical and neurological
scores was observed in 20 (90 %) calves, a full recovery
in only 1 (5 %). No worsening of clinical conditions was
observed or further treatments required at the one-
month follow-up. The agreement between neurological
deficits and otoscopy was 77 %.
Laboratory findings
Hemocromocytometric and serum biochemical findings
were unremarkable. CSF analysis of samples from 21 calves
was abnormal in 5 (reference limits: total cell count <10
cells/μL; microproteins <40 mg/dL). One sample was
excluded due to severe blood contamination. Mild mono-
nuclear pleocytosis was observed in CSF samples from
2 calves (total cell count 12 cells/μL and microproteins
20.53 mg/dL; total cell count 11 cells/μL and microproteins
20.94 mg/dL, respectively). Neutrophilic pleocytosis was
found in CSF samples from 2 other calves (total cell count
95 cells/μL and microproteins 163.2 mg/dL; total cell count
50 cells/μL, microproteins 43.91 mg/dL, respectively). Albu-
minocytological dissociation was detected in 1 animal (total
cell count 8 cells/μL; microproteins 72.3 mg/dL). Table 3
presents the results of bacterial and mycoplasmal cultures
from affected ears, upper and lower respiratory tract.
Aural swabs and lavages tested positive for M. bovis in
79 and 89 % of cases, respectively; the observed agreement
Fig. 2 Most common neurological findings at diagnosis (T0) and 2 weeks after therapy (T2)
Fig. 3 Boxplots representation of clinical scores at T0, T1 and T2. The
boxplots depict the minimum and maximum values, the upper (Q3)
and lower (Q1) quartiles and the median. The median is identified
by a line inside the box. The length of the box represents the
interquartile range. Values that deviate appreciably from most of the
measurements in the data set are labeled as outliers (o)
Fig. 4 Boxplots representation of neurological scores at T0, T1 and
T2. The boxplots depict the minimum and maximum values, the
upper (Q3) and lower (Q1) quartiles and the median. The median is
identified by a line inside the box. The length of the box represents
the interquartile range. Values that deviate appreciably from most of
the measurements in the data set are labeled as outliers (o)
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between samples from aural swabs and lavages was 77 %.
M. bovis was isolated in 3 out of 16 aural swabs collected
from clinically healthy contralateral ears in association
with Streptococcus (n = 1), P. multocida (n = 1), and mixed
bacterial flora (n = 1), respectively. Table 4 reports the dis-
tribution of the causative agents isolated from the ears
and respiratory tract. Overall, M. bovis, either alone or to-
gether with another bacterial agent, was isolated from the
upper and/or lower respiratory tract in 19 (86 %) calves;
M. bovis was isolated from the upper and/or lower re-
spiratory tract in 10 out of 11 calves with respiratory
signs.
Discussion
With this study we evaluated, in field conditions and by
means of a simple scoring system, clinicopathological
findings in calves with OM/OMI and the clinical efficacy
of a standardized therapeutic protocol. Also, we identified
associated causative agents and their possible correlation
with concurrent BRD. As in previous studies [2, 5, 6], veal
calves made up the majority of the study population,
though the incidence of OMI in dairy calves seems to be
rising [6, 10]. Most reports state that males and females
seem to be equally susceptible to the infection [7, 8, 10];
however, Lamm et al. [7] reported that males are more
prone to M. bovis infection because they are fed poor
quality milk and do not receive adequate colostrum. In
the present study, the males far outnumbered the females
(18 vs. 4) which is likely to be related with the type of
breeding (veal calves) since males are reared more often
than females. Seeking possible correlations between
the consumption of wasted milk and the pathogenesis
of OMI was beyond the scope of this study. Inclem-
ent weather seems to be a predisposing factor for the
development of OM/OMI [5–9]. Indeed, the majority
(73 %) of the calves were referred during the autumn
and winter months.
The presenting complaints/clinical signs, neurological
signs, and the frequency of unilateral/bilateral ear in-
volvement were consistent with previous observations
[1, 7, 8, 10, 11, 15]; moreover, the persistence of mild
clinical and neurological signs at T2 did not affect the
animals’ mental status, appetite or weight gain, as ascer-
tained by telephone interviews with the owners. These
findings are in line with evidence that animals tend to
adapt and thrive despite the persistence of neurological
signs [8, 10, 22]. Persistent head tilt seems to be a prob-
lem only in valuable animals [8, 10].
Scoring systems for the evaluation of gait, acute post-
operative pain, and sepsis in cattle have been validated
and found to be reliable and sensitive for assessing the
severity of clinical signs [23, 24]. To the best of our
knowledge, there are no validated scoring systems for
evaluating clinical signs and/or response to therapy in
Fig. 5 Boxplots representation of the final total scores assigned at
T0, T1, and T2. The boxplots depict the minimum and maximum
values, the upper (Q3) and lower (Q1) quartiles and the median. The
median is identified by a line inside the box. The length of the box
represents the interquartile range. Values that deviate appreciably
from most of the measurements in the data set are labeled as
outliers (o)
Table 3 Results of bacterial and mycoplasmal cultures
Bacterial colture results Affected Ears Respiratory tract
Swabs Lavages Swabs TBA
n = 28 n = 28 n = 22 n = 20
M. bovis 16 18 14 9
M. bovis and P. multocida 5 5 2 3
M. bovis and Streptococcus spp. 1 - 1 -
M. bovis and Staphylococcus spp. - 1 - -
M. bovis and P. multocida + Streptococcus spp. - - 1 -
M. bovis and Pseudomonas spp. - 1 - -
Mycoplasma spp. - - 2 1
P. multocida 1 - - -
No bacteria 4 1 1 7
Contaminated samples (not diagnostic) 1 2 1 -
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calves with OM/OMI. Therefore, we applied two numer-
ical scoring systems to objectively quantify clinical and
neurological findings, respectively, at each experimental
time point.
Abnormal CSF analysis results are suggestive of central
nervous system (CNS) involvement [8]. None of the
calves in the present study showed neurological signs
consistent with central vestibular disease; however, the
CSF abnormalities in five animals could be explained by
a focal spread of infection to the CNS. Indeed, the inner
ear communicates with the subarachnoid space through
the cochlear canaliculus [25]. The use of diagnostic im-
aging, such as computed tomography (CT) or magnetic
resonance imaging (MRI), could help to clarify this [26].
Unfortunately, this was not possible since the study was
conducted in the field.
To date, different therapeutic approaches have been
used in calves for the treatment of OM/OMI, but pro-
spective studies evaluating the efficacy of a standardized
protocol are lacking. Furthermore, because there are no
licensed drugs for the treatment of these disorders, ac-
tive against Mycoplasma spp., in calves, optimal therapy
remains to be determined and extra-label drug use is re-
quired [1, 8]. For the purpose of this survey, however, a
randomized, double-blind placebo control study was not
designed for ethical reasons and animal welfare, since
meningitis and meningoencephalitis can develop second-
ary to the extension of infection [1, 10].
Our results suggest that, under the standardized thera-
peutic protocol applied in this study, the combined use of
tulathromycin (Draxxin®; Pfizer), oxytetracycline hydro-
chloride (Terramicina 100®; Zoetis), and carprofen
(Rimadyl®, Zoetis) might be effective for the treatment of
OM/OMI in calves. Significant clinico-neurological im-
provement was observed after 2 weeks of treatment in
95 % of the calves and full recovery was achieved in only
one animal. Prompt initiation of therapy (within 12–24 h
after the onset of clinical signs) was probably key to symp-
tom improvement since prognosis seems to be more fa-
vorable when therapy is begun early in the course of the
disease [2, 9, 27].
Tulathromycin, a novel, semi-synthetic macrolide bac-
teriostatic antimicrobial, is active against M. bovis and other
bacterial respiratory pathogens in cattle. Following paren-
teral administration, it is rapidly adsorbed and widely dis-
tributed, and has a long elimination half-life in lung tissue
[28]. It acts by inhibiting protein synthesis in susceptible
microorganisms. Once penetrated into the bacterial cell, it
irreversibly binds to receptors of the 30S ribosomal sub-
units [29]. In a retrospective study [10], tulathromycin was
administered for the treatment of OMI in calves, but no
data about the number of treated animals or its efficacy are
available. Oxyteracycline hydrochloride, a bacteriostatic,
broad-spectrum tetracycline antibiotic, is widely distributed
throughout the body. Although resistance of European
mycoplasma strains to oxytetracycline has been reported
[30, 31], it is effective against bacteria causing OMI, espe-
cially with prolonged use [11]. It acts similarly to tulathro-
mycin by irreversibly binding to receptors of the 50S
ribosomal units [29]. In the present study tulathromycin
and oxitetracycline hydrochloride have been used together
as the association between bacteriostatic antibiotics can de-
termine the summation of their individual effects [29]. Car-
profen, a nonsteroidal anti-inflammatory drug, was added
to antibiotic therapy to reduce rectal temperature and pain
[1]. To date, combined use of anti-inflammatory drugs and
antibiotics has been evaluated only in the treatment of BRD
complex [32–34]; however, its efficacy is controversial [35].
As reported elsewhere, M. bovis, either alone or in associ-
ation with P. multocida, Streptococcus spp., Staphylococcus
spp. and Pseudomonas, was the most frequently isolated
pathogen [7, 8, 10]. Indeed, it has been demonstrated that
Table 4 Distribution of the causative agents isolated from the ears and respiratory tract
Respiratory tract M. bovis M. bovis + M. bovis + M. bovis + Mycoplasma spp. Other mixed
bacteriaP. multocida Streptococcus spp. Streptococcus spp. +Ears
P. Multocida
M. bovis 9 (4a; 1b; 4c) 1b - 1a 1c 1a
M. bovis + 2c 3 (1a; 1b; 1c) - - 1a -
P. multocida
M. bovis + 1a - - - - -
Staphylococcus spp.
M. bovis + - - 1a - - -
Streptococcus spp.
M. bovis + 1a - - - - -
Pseudomonas spp.
anasal swabs
bTBA
cnasal swabs and TBA
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under opportune conditions many bacterial species
colonize the middle ear [1]. Respiratory tract infections,
often with the same pathogen, have been reported in
calves with OMI [1, 2, 8]. Also in this study M. bovis was
isolated from the upper and/or lower respiratory tract in
10 out of 11 calves with respiratory signs in which the
OMI may have developed secondary to respiratory dis-
ease. The most common risk factor for OMI appears to be
respiratory tract infections [1]: respiratory pathogens
colonize the pharynx and tonsils and eventually the audi-
tory tube, which represents the major route of infection in
OMI [1]. The isolation of M. bovis, either alone or in asso-
ciation with other bacteria, from the aural swabs taken
from the clinically healthy ears (n = 3) is in agreement
with previous reports in which Mycoplasma spp. was har-
bored in the ears of apparently healthy animals [1]. As the
host-mycoplasma relationship is complicated and many
aspects of these interactions are poorly understood [36],
further studies are needed to understand the role of this
pathogen when its presence does not result in disease.
Conclusion
In conclusion, this is the first prospective study to evaluate
the effectiveness of a standardized therapeutic protocol
for the treatment of OM/OMI in calves. A significant im-
provement in symptoms was observed in the majority of
the calves. The persistence of mild clinico-neurological
signs did not compromise the animals' productive per-
formance. The numerical scoring system for assessing
clinical and neurological signs was a useful tool to object-
ively evaluate the response to therapy. M. bovis was the
pathogen most often isolated. This finding should be con-
sidered when treating OM/OMI in calves. Also, respira-
tory tract infection should not be underrated, since it is
one of the major risk factors for the development of OM/
OMI.
Endnotes
1Calf Respiratory Scoring Chart http://www.vetmed.
wisc.edu/dms/fapm/fapmtools/8calf/calf_respiratory_
scoring_chart.pdf
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